Company intelligence / Profile preview

Haining Leili Biotechnology

Haining, Zhejiang, China

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Haining Leili Biotechnology is a high-tech enterprise specializing in the R&D and industrial production of synthetic capsaicin (nonivamide). The company provides high-purity synthetic capsaicin for pharmaceutical applications as an analgesic and anti-inflammatory agent, as well as for agricultural biopesticides and industrial rodent-proof and antifouling additives. They hold independent intellectual property rights for their synthetic capsaicin production technology and export their products globally.

Therapeutic areas: RheumatologyImmunologyNeurologyDermatology
Modalities: Small molecule
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Haining Leili Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haining Leili Biotechnology.

Explore the full profile